Hydrocortisone, heparin, and peripheral intravenous infusion. 1994

C Roongpisuthipong, and O Puchaiwatananon, and S Songchitsomboon, and S Kanjanapanjapol
Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

We studied the effect of low-dose hydrocortisone and heparin added to peripheral intravenous fluid on episodes and severity of thrombophlebitis. Osmolal solutions of 860 mOsm/kg H2O with heparin and hydrocortisone (feed A) and without heparin and hydrocortisone (feed B) were infused into surgical and ear, nose, and throat patients for peripheral intravenous nutrition. The addition of heparin (500 U/L) and hydrocortisone (10 mg/L) in 10% dextrose in half-strength normal saline and 500 ml 5% crystalline amino acid solution infused simultaneously via a Y line significantly reduced the episodes and severity of thrombophlebitis. Thus, the administration of low-dose hydrocortisone and heparin with peripheral fluids is beneficial in preventing thrombophlebitis.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D010288 Parenteral Nutrition The administering of nutrients for assimilation and utilization by a patient who cannot maintain adequate nutrition by enteral feeding alone. Nutrients are administered by a route other than the alimentary canal (e.g., intravenously, subcutaneously). Intravenous Feeding,Nutrition, Parenteral,Parenteral Feeding,Feeding, Intravenous,Feeding, Parenteral,Feedings, Intravenous,Feedings, Parenteral,Intravenous Feedings,Parenteral Feedings
D005260 Female Females
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

C Roongpisuthipong, and O Puchaiwatananon, and S Songchitsomboon, and S Kanjanapanjapol
January 1994, Nutrition (Burbank, Los Angeles County, Calif.),
C Roongpisuthipong, and O Puchaiwatananon, and S Songchitsomboon, and S Kanjanapanjapol
January 1988, Indian journal of physiology and pharmacology,
C Roongpisuthipong, and O Puchaiwatananon, and S Songchitsomboon, and S Kanjanapanjapol
January 1994, The Annals of pharmacotherapy,
C Roongpisuthipong, and O Puchaiwatananon, and S Songchitsomboon, and S Kanjanapanjapol
October 1983, Chest,
C Roongpisuthipong, and O Puchaiwatananon, and S Songchitsomboon, and S Kanjanapanjapol
January 1995, JPEN. Journal of parenteral and enteral nutrition,
C Roongpisuthipong, and O Puchaiwatananon, and S Songchitsomboon, and S Kanjanapanjapol
October 1971, American journal of hospital pharmacy,
C Roongpisuthipong, and O Puchaiwatananon, and S Songchitsomboon, and S Kanjanapanjapol
July 2008, Clinical biochemistry,
C Roongpisuthipong, and O Puchaiwatananon, and S Songchitsomboon, and S Kanjanapanjapol
January 1980, American journal of hospital pharmacy,
C Roongpisuthipong, and O Puchaiwatananon, and S Songchitsomboon, and S Kanjanapanjapol
April 1972, American journal of hospital pharmacy,
C Roongpisuthipong, and O Puchaiwatananon, and S Songchitsomboon, and S Kanjanapanjapol
April 1972, American journal of hospital pharmacy,
Copied contents to your clipboard!